CLINICAL_TRIALS
trial_result
· 2024-04-09
Clinical Trial Update: A Study of Olaparib and Durvalumab in Prostate Cancer [Phase 2]
Summary
Phase 2 trial investigating olaparib plus durvalumab in prostate cancer was terminated; results posted in 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2024-04-09